3M (MMM)
(Delayed Data from NYSE)
$98.20 USD
+0.64 (0.66%)
Updated May 30, 2024 04:00 PM ET
After-Market: $98.19 -0.01 (-0.01%) 7:58 PM ET
5-Strong Sell of 5 5
D Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$98.20 USD
+0.64 (0.66%)
Updated May 30, 2024 04:00 PM ET
After-Market: $98.19 -0.01 (-0.01%) 7:58 PM ET
5-Strong Sell of 5 5
D Value A Growth D Momentum B VGM
Zacks News
Conglomerate 3M’s focus on business transformation — with moves like the localization of decision making and integration of supply chains — enhances its competitive advantage. Also, its recognized product brands and investments in innovation are compelling. Inorganic actions (buyouts and divestments) are added advantages. Acelity, bought in October 2019, is predicted to aid 3M’s medical solutions business. Being one of the largest manufacturers of respiratory masks, the coronavirus outbreak has added to the company’s growth potential.